Ventas Q3 Net Income Soars on Strong Senior Housing Demand

Ticker: VTR · Form: 10-Q · Filed: 2025-10-30T00:00:00.000Z

Sentiment: bullish

Topics: REIT, Healthcare Real Estate, Senior Housing, Medical Office Buildings, Earnings Growth, Debt Management, Capital Expenditures

Related Tickers: VTR, HCN, WELL, SBRA, OHI

TL;DR

**VTR is crushing it with senior housing demand, making it a solid bet for long-term growth.**

AI Summary

Ventas, Inc. (VTR) reported a significant increase in net income for the nine months ended September 30, 2025, reaching $188.5 million, a substantial rise from $29.6 million in the same period of 2024. Total revenues also saw a healthy increase, climbing to $4.27 billion for the nine months ended September 30, 2025, up from $3.64 billion in the prior year. This revenue growth was primarily driven by a surge in resident fees and services, which increased to $3.09 billion from $2.48 billion. The company's Senior Housing Operating Portfolio (SHOP) generated $853.2 million in Net Operating Income (NOI), representing 48.1% of total NOI, while the Outpatient Medical and Research (OM&R) portfolio contributed $440.3 million (24.8% of NOI). Total assets grew to $26.93 billion as of September 30, 2025, from $26.19 billion at December 31, 2024, largely due to an increase in net real estate property to $23.92 billion. However, cash and cash equivalents decreased significantly to $188.6 million from $897.8 million, and senior notes payable and other debt decreased to $12.57 billion from $13.52 billion, indicating debt reduction efforts. The company also issued $2.06 billion in common stock, net, during the nine months ended September 30, 2025, compared to $850.6 million in the prior year, bolstering its equity base.

Why It Matters

Ventas's robust performance, particularly in its Senior Housing Operating Portfolio, signals a strong recovery and growing demand in the senior care sector, which is crucial for investors looking at demographic trends. The significant increase in net income and revenue suggests effective management and strategic positioning, potentially leading to higher shareholder returns. For employees, this growth could mean job stability and expansion opportunities within Ventas's diverse healthcare real estate portfolio. Customers, primarily residents in senior housing, benefit from continued investment in properties and services. In the broader market, Ventas's success could encourage further investment in healthcare real estate, intensifying competition but also driving innovation in the sector.

Risk Assessment

Risk Level: medium — While Ventas shows strong revenue and net income growth, the significant decrease in cash and cash equivalents from $897.8 million to $188.6 million within nine months, coupled with a substantial increase in net investment in real estate property by $1.47 billion, indicates aggressive capital deployment. This could strain liquidity if market conditions shift or if new investments do not yield expected returns. Additionally, the company's retained earnings deficit increased to $(7.37) billion from $(6.89) billion, suggesting ongoing challenges in generating sufficient retained earnings despite improved net income.

Analyst Insight

Investors should consider Ventas's strong operational performance and strategic investments in senior housing and medical facilities as a positive indicator. However, they should closely monitor the company's cash flow and debt management strategies, especially given the significant reduction in cash and increased capital deployment. A deeper dive into the specifics of the $2.06 billion common stock issuance and its impact on dilution would also be prudent.

Financial Highlights

revenue
$4.27B
total Assets
$26.93B
total Debt
$12.57B
net Income
$188.5M
cash Position
$188.6M
revenue Growth
+17.3%

Revenue Breakdown

SegmentRevenueGrowth
Resident fees and services$3.09B+24.8%
Outpatient medical and research portfolio$668.3M+1.5%
Triple-net leased properties$468.9M+0.9%
Third-party capital management revenues$13.2M+1.5%

Key Numbers

Key Players & Entities

FAQ

What were Ventas's total revenues for the nine months ended September 30, 2025?

Ventas's total revenues for the nine months ended September 30, 2025, were $4.27 billion, a notable increase from $3.64 billion reported for the same period in 2024.

How did Ventas's net income change for the nine months ended September 30, 2025, compared to the previous year?

Net income attributable to common stockholders for Ventas increased significantly to $181.18 million for the nine months ended September 30, 2025, up from $24.32 million in the prior year.

Which business segment contributed the most to Ventas's Net Operating Income (NOI) in the nine months ended September 30, 2025?

The Senior Housing Operating Portfolio (SHOP) was the largest contributor to Ventas's NOI, generating $853.2 million, which accounted for 48.1% of the total NOI for the nine months ended September 30, 2025.

What was the change in Ventas's cash and cash equivalents as of September 30, 2025?

Ventas's cash and cash equivalents decreased to $188.6 million as of September 30, 2025, from $897.8 million at December 31, 2024, representing a significant reduction in liquidity.

How much common stock did Ventas issue, net, during the nine months ended September 30, 2025?

Ventas issued $2.06 billion in common stock, net, during the nine months ended September 30, 2025, which is a substantial increase compared to $850.6 million in the same period of 2024.

What is Ventas's primary business focus as a REIT?

Ventas, Inc. is a real estate investment trust (REIT) focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population, primarily through senior housing communities, outpatient medical buildings, and research centers.

What are the three reportable business segments for Ventas?

Ventas operates through three reportable business segments: the senior housing operating portfolio (SHOP), the outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN).

Did Ventas reduce its debt during the nine months ended September 30, 2025?

Yes, Ventas reduced its senior notes payable and other debt to $12.57 billion as of September 30, 2025, down from $13.52 billion at December 31, 2024.

What was the total net investment in real estate property for Ventas during the nine months ended September 30, 2025?

Ventas reported a net investment in real estate property of $(1.99) billion for the nine months ended September 30, 2025, indicating significant capital deployment into its real estate portfolio.

What is the significance of Ventas's election to be taxed as a REIT?

By electing to be taxed as a REIT, Ventas generally is not required to pay U.S. federal corporate income taxes on its REIT taxable income that is currently distributed to its stockholders, provided it satisfies specific technical requirements.

Risk Factors

Industry Context

Ventas operates within the healthcare real estate sector, a market influenced by demographic trends such as an aging population, evolving healthcare delivery models, and interest rate sensitivity. The company's diversified portfolio across senior housing, outpatient medical, and triple-net leased properties positions it to capitalize on these trends. Competition exists from other healthcare REITs and private real estate investors, with a focus on operational efficiency and property management.

Regulatory Implications

As a REIT, Ventas is subject to stringent IRS regulations regarding income, assets, and distributions to maintain its tax-advantaged status. Changes in healthcare regulations, zoning laws, and environmental standards can also impact property operations and development. The recent SEC climate-related disclosure rule, though currently stayed, indicates a growing focus on ESG reporting.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]
  5. [object Object]

Key Dates

Glossary

REIT
Real Estate Investment Trust. A company that owns, operates, or finances income-generating real estate. REITs are required to distribute at least 90% of their taxable income to shareholders annually. (Ventas operates as a REIT, which dictates its tax structure and operational requirements.)
NOI
Net Operating Income. A calculation of profitability for real estate assets, typically defined as total revenue less operating expenses, excluding depreciation, amortization, interest expense, and income taxes. (Key metric for assessing the profitability of Ventas's property portfolios, particularly SHOP and OM&R.)
SHOP
Senior Housing Operating Portfolio. Refers to Ventas's segment focused on senior housing communities that are operated by the company. (A major segment contributing significantly to Ventas's overall NOI.)
OM&R
Outpatient Medical and Research. Refers to Ventas's segment comprising outpatient medical buildings and research centers. (Another key segment contributing to Ventas's NOI.)
GAAP
Generally Accepted Accounting Principles. The common set of accounting principles, standards, and procedures that companies must follow when they compile their financial statements. (The accounting framework used for Ventas's financial reporting.)
VIEs
Variable Interest Entities. Entities for which the voting interest is not sufficient to control the entity, and control is achieved through contractual arrangements. (Ventas consolidates certain VIEs, impacting its balance sheet and financial reporting.)

Year-Over-Year Comparison

Ventas has demonstrated robust top-line growth, with total revenues increasing by 17.3% to $4.27 billion for the nine months ended September 30, 2025, compared to the prior year. This growth is primarily fueled by a significant 24.8% surge in resident fees and services. Net income has also seen a dramatic improvement, rising to $188.5 million from $29.6 million. However, this period is marked by a substantial decrease in cash and cash equivalents, down from $897.8 million to $188.6 million, while equity has been significantly bolstered through increased common stock issuance. Total assets have grown modestly, and total debt has been reduced.

Filing Stats: 4,608 words · 18 min read · ~15 pages · Grade level 16.9 · Accepted 2025-10-30 16:24:40

Key Financial Figures

Filing Documents

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION Item 1. Consolidated Financial Statements (Unaudited) 1 Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024 1 Consolidated Statements of Income for the Three and Nine Months Ended September 30, 2025 and 2024 2 Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended September 30, 2025 and 2024 3 Consolidated Statements of Equity for the Three and Nine Months Ended September 30, 2025 and 2024 4 Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 6

Notes to Consolidated Financial Statements

Notes to Consolidated Financial Statements 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 32 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 62 Item 4.

Controls and Procedures

Controls and Procedures 65

—OTHER INFORMATION

PART II—OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 66 Item 1A.

Risk Factors

Risk Factors 66 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 66

Defaults Upon Senior Securities 66

Item 3. Defaults Upon Senior Securities 66

Mine Safety Disclosures 66

Item 4. Mine Safety Disclosures 66 Item 5. Other Information 67 Item 6. Exhibits 68 Table of Contents

—FINANCIAL INFORMATION

PART I—FINANCIAL INFORMATION

CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS VENTAS, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except per share amounts, unaudited) As of September 30, 2025 As of December 31, 2024 Assets Real estate investments: Land and improvements $ 2,921,732 $ 2,775,790 Buildings and improvements 30,488,097 28,717,990 Construction in progress 345,988 336,231 Acquired lease intangibles 1,661,521 1,558,751 Operating lease assets 299,490 308,019 35,716,828 33,696,781 Accumulated depreciation and amortization ( 11,792,468 ) ( 11,096,236 ) Net real estate property 23,924,360 22,600,545 Secured loans receivable and investments, net 182,504 144,872 Investments in unconsolidated real estate entities 653,328 626,122 Net real estate investments 24,760,192 23,371,539 Cash and cash equivalents 188,617 897,850 Escrow deposits and restricted cash 53,934 59,383 Goodwill 1,046,039 1,044,915 Assets held for sale 70,086 18,625 Deferred income tax assets, net 2,317 1,931 Other assets 804,519 792,663 Total assets $ 26,925,704 $ 26,186,906 Liabilities and equity Liabilities: Senior notes payable and other debt $ 12,571,614 $ 13,522,551 Accrued interest payable 113,252 143,345 Operating lease liabilities 216,108 218,003 Accounts payable and other liabilities 1,226,390 1,152,306 Liabilities related to assets held for sale 3,708 2,726 Deferred income tax liabilities 20,923 8,150 Total liabilities 14,151,995 15,047,081 Redeemable OP unitholder and noncontrolling interests 349,951 310,229 Commitments and contingencies Equity: Ventas stockholders' equity: Preferred stock, $ 1.00 par value; 10,000 shares authorized, unissued — — Common stock, $ 0.25 par value; 1,200,000 and 600,000 shares authorized at September 30, 2025 and December 31, 2024, respectively, 469,449 and 437,085 shares outstanding at September 30, 2025 and December 31, 2024, respectively 116,939 109,119 Capital in excess of par value 19,695,187 17,607,482 Accumulated other comprehensive loss (

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) NOTE 1—DESCRIPTION OF BUSINESS Ventas, Inc., (together with its consolidated subsidiaries, unless otherwise indicated or except where the context otherwise requires, "we," "us," "our," "Ventas," "Company" and other similar terms) is a real estate investment trust ("REIT") focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. We hold a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. As of September 30, 2025, we owned or had investments in 1,406 properties consisting of 1,371 properties in our reportable business segments ("Segment Properties") and 35 properties held by unconsolidated real estate entities in our non-segment operations. Our Company is headquartered in Chicago, Illinois with additional corporate offices in Louisville, Kentucky and New York, New York. We elected to be taxed as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the "Code"), commencing with our taxable year ended December 31, 1999. Provided we qualify for taxation as a REIT, we generally are not required to pay U.S. federal corporate income taxes on our REIT taxable income that is currently distributed to our stockholders. In order to maintain our qualification as a REIT, we must satisfy a number of technical requirements, which impact how we invest in, operate and manage our assets. We operate through three reportable business segments: senior housing operating portfolio, which we refer to as "SHOP," outpatient medical and research portfolio, which we refer to as "OM&R," and triple-net leased properties, which we refer to as "NNN." We also hold assets outside of our reportable business segments, which we refer to as non-segment assets, and which consist primari

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) (2) NOI for non-segment includes management fees and promote revenues, net of expenses related to our third-party institutional private capital management platform, income from loans and investments and corporate-level expenses not directly attributable to any of our three reportable business segments. n/a— not applicable NOTE 2—ACCOUNTING POLICIES The accompanying Consolidated Financial Statements have been prepared in accordance with GAAP for interim financial information set forth in the Accounting Standards Codification ("ASC"), as published by the Financial Accounting Standards Board ("FASB"), and with the Securities and Exchange Commission ("SEC") instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim periods have been included. Operating results for the three and nine months ended September 30, 2025 are not necessarily indicative of the results that may be expected for the year ending December 31, 2025. The accompanying Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Annual Report"). Accounting Estimates The preparation of financial statements in accordance with GAAP requires us to make estimates and assumptions regarding future events that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Principles

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) Recent Accounting Standards In December 2023, the FASB issued Accounting Standards Update 2023-09, Improvements to Income Tax Disclosures ("ASU 2023-09"), which requires public entities on an annual basis to (i) disclose specific categories in the rate reconciliation and (ii) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income or loss by the applicable statutory income tax rate). ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. We have elected not to early adopt. We are finalizing our assessment of the impact of ASU 2023-09 and expect to include additional required disclosures in our 2025 annual report on Form 10-K. In March 2024, the SEC adopted the final rule under SEC Release No. 33-11275, The Enhancement and Standardization of Climate Related Disclosures for Investors , which requires registrants to disclose climate-related information in registration statements and annual reports. The new rule would be effective for annual reporting periods beginning in fiscal year 2025. In April 2024, the SEC exercised its discretion to stay this rule and, subsequently, in March 2025, the SEC voted to end its defense of the rule against certain legal challenges. We are monitoring the ongoing judicial review of these legal challenges to determine the impact, if any, of the rule on our Consolidated Financial Statements. On November 4, 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses ("DISE"), which requires disaggregated disclosure of income statement expenses for public business entities ("PBEs"). ASU 2024-03 requires PBEs to include footnote disclosure that disaggregates, in a tabular presentation, each relevant expense caption on the face of the income statement that includes certain natural

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited) The following table summarizes certain information about our credit risk concentration for our NNN and OM&R segments: For the Three Months Ended September 30, For the Nine Months Ended September 30, 2025 2024 2025 2024 Contribution as a Percentage of Total Revenues: Brookdale (1) 2.8 % 3.1 % 2.9 % 3.1 % Ardent 2.

View on Read The Filing